Support Future Generations of Scientists: Take a Short Survey

By Kristie Grover

Director of the BIOCOM Institute

The Obama administration recently launched the “Educate to Innovate” campaign, a nationwide effort to motivate and inspire young people across America to excel in science and math. The administration realizes however that while federal leadership is necessary, a real change in STEM (science, technology, engineering and math) education requires the participation of many elements of society, including governors, philanthropists, scientists, engineers, educators, and the private sector.

That is why the President Obama’s speech at the National Academy of Sciences challenged all Americans to join the cause of elevating STEM education as a national priority.

The life science industry can take hold of this ethic of service and can make a commitment to the enhance science literacy within San Diego. The BIOCOM Institute would like to put this kind of support to good use. We are organizing activities to help schools infuse real world examples of science.

The BIOCOM Institute has created an opportunity for life science professionals to enhance science curriculum with real-world applications in science. Called the Science Education Speakers Bureau (SESB), this program matches industry professionals from business, research and higher education with middle school classroom volunteer teaching/speaking opportunities. The ultimate goal of this innovative program is to improve education in science, technology, engineering, and mathematics, or the STEM disciplines.

The following survey will take only a couple minutes and assist us in best supporting future generations of science and technology leaders.

http://www.surveymonkey.com/s/ScienceEducationVolunteerSurvey

Thanks for your support!

« Return to Table of Contents

Life Sciences LIVE at the San Diego Opera

Tickets are on sale now for the 14th Annual Life Sciences LIVE at the Opera on Friday, March 19, 2010.

Please join 2010 Co-Chairs: Marsha A. Chandler, Ph.D., of The Salk Institute for Biological Studies, Harry F. Hixson, Jr., Ph.D., of BrainCells, Inc., Joe Panetta, President and Chief Executive officer of BIOCOM and Ivor Royston, M.D., of Forward Ventures as they lead the way for this year’s unparalleled industry initiative and appreciate a night out at Opera for a beautiful production of Charles Gounod’s Romeo and Juliet.. Special event packages start at $155 per person and include VIP seating as well as admission to the pre-opera networking reception and dessert reception during Intermission. Last year over 300 Biotech professionals were in attendance - and this year looks just as promising! Please make your reservations in advance, as ticket inventory for Romeo and Juliet is limited, and seats are going quickly.

For full details, pricing and seating chart, please visit: www.sdopera.com/live

« Return to Table of Contents

LifeLines Magazine Highlights Southern California’s Life Saving Innovation

LifeLines magazine, BIOCOM’s quarterly publication, covers Southern California’s life science industry, its innovation and its newsmakers that are saving lives and changing health care. More than 5,000 people across the nation receive LifeLines, including industry CEOs and other top-level decision makers. To subscribe to LifeLines, or learn about advertising opportunities, please contact Terri Somers, BIOCOM’s Director of Communications.

« Return to Table of Contents

Xconomy Forum: San Diego Life Sciences 2030

Wednesday, March 31, 2010
6:00 pm - 8:30 pm

San Diego biotech has taken its share of lumps lately, but beyond the next quarter or next year, what kind of life sciences potential really exists here? What will the San Diego life sciences landscape look like 20 years from now? Will the region have grown as a world leader in university and corporate research, venture financing, and entrepreneurial activity? Which particular fields of life sciences and healthcare will be the most vibrant? We will bring together a select group of innovators and visionaries in the heart of La Jolla for an intimate, interactive discussion of these and other key questions about the future of San Diego-area life sciences.



Welcoming Remarks:

  • John Dunn, Executive Vice President, Biogen Idec New Ventures

Panelists:

  • John Mendlein (moderator), Chairman of the Board, Fate Pharmaceuticals
  • Paul Schimmel, Professor of Chemical Biology, The Scripps Research Institute; Cofounder or founding director of eleven biotechnology companies, of which six (Alkermes, Alnylam Pharmaceuticals, Avicena Group, Cubist Pharmaceuticals, Momenta Pharmaceuticals, Repligen Corporation) are publicly traded.
  • Dan Bradbury, President and CEO, Amylin Pharmaceuticals; Chairman of BIOCOM
  • Fred "Rusty" Gage, Professor and Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, Salk Institute for Biological Studies

Schedule:
Registration Opens: 5:15 pm
Program: 6:00 pm - 7:30 pm
Reception: 7:30 pm - 8:30 pm

Location:
Biogen Idec
Research & Corporate Campus

5200 Research Place

San Diego, CA 92122

Registration Information

BIOCOM Members rate: $50 (enter promotional code BIOCOM)

Early Bird Registration: $75.00 (ends March 10)
Regular Registration - $95.00

Student Registration - $20 (Limited number available. Valid student ID must be shown at registration desk.)

Walk-in Registration - $125.00

Tickets are transferable but not refundable.


CLICK TO REGISTER

« Return to Table of Contents

BIOCOM Thanks its Renewing Members

Anadys Pharmaceuticals

Arena Pharmaceuticals

CSU San Marcos

Deloitte

EyeCyte

Human Biomolecular Research Institute

Jones Day

Minnow Medical

Morrison & Foerster LLP

Phenomix

Receptos, Inc.

Regulus Therapeutics

SkinMedica, Inc.

UCSD Extension

« Return to Table of Contents

BIOCOM Welcomes New Members

BIOCOM is proud to welcome the following new members to the association.

DevicePharm:

At DevicePharm, our entire focus is on providing marketing strategy and planning as well as integrated marketing solutions for our medical device and pharmaceutical clients. We can't impress you with our latest success in marketing blue jeans, but we can tell you about a program that generated participation
by 94 percent of the top North American cardiovascular physicians in its first year. We can't tell you about our success in marketing automobiles, but we can tell you about our ability to create consistent global brand messaging for a leading medical device company.

IGE Therapeutics, Inc.:

IGE Therapeutics, Inc. innovates universal IgE allergy peptide treatment to treat severity of allergic syndromes and alter the natural course of allergic asthma and rhinitis.

MyOffice Facility Solutions:

MyOffice is an integrated turn-key service provider, eliminating the need to manage multiple vendors required for projects. Our “Core 4” lineup includes Corporate Relocation, Furniture Installation, Cabling, and Office Technologies (Telephony, ACS, CCTV, and A/V).

Senju USA, Inc.:

Established in April 2006 Senju USA, Inc is working towards the development of new and exciting products . We're a team of business development and clinical development members who are working together with the same goal in sight---better products for ophthalmic patients.

« Return to Table of Contents